IL-13, Recombinant, Cotton Rat, 5-His-tag (Interleukin 13, IL13)

IL-13 is a 17kD immunoregulatory cytokine that plays a key role in the pathogenesis of allergic asthma and atopy. It is secreted by Th1 and Th2 CD4+ T cells, NK cells, visceral smooth muscle cells, eosinophils, mast cells, and basophils. IL-13 circulates as a monomer with two internal disulfide bonds that contribute to a bundled four A-helix configuration. Mature cotton rat IL-13 shares 59%, 74%, and 72% aa sequence identity with human, mouse, and rat IL-13, respectively. Despite the low homology, it exhibits cross-species activity between human, mouse, and rat. IL-13 has diverse activities on numerous cell types. On macrophages, IL-13 suppresses the production of proinflammatory cytokines and other cytotoxic substances. On B cells, IL-13 induces immunoglobulin class switching to IgE, up-regulates the expression of MHC class II, CD71, CD72, and CD23, and costimulates proliferation. IL-13 up-regulates IL-6 while down-regulating IL-1 and TNF-A production by fibroblasts and endothelial cells. IL-13 binds with low affinity to IL-13 RA1, triggering IL-13 RA1 association with IL-4 RA. This high affinity receptor complex also functions as the type 2 IL-4 receptor complex. Additionally, IL-13 binds with high affinity to IL-13 RA2 which is expressed intracellularly, on the cell surface, and as a soluble molecule. IL-13 RA2 regulates the bioavailability of both IL-13 and IL-4 and is overexpressed in glioma and several bronchial pathologies. Compared to wild type IL-13, the atopy-associated R110Q variant of IL-13 elicits increased responsiveness from eosinophils that express low levels of IL-13 RA2.\n\nSource:\nRecombinant corresponding to aa1-133 from cotton rat IL-13, fused to 5-His-tag at C-terminal expressed in CHO cell line.\n\nMolecular Weight:\n~13.1kD\n\nBiological Activity:\nMeasured in a cell proliferation assay using TF-1 human erythroleukemic cells. The ED50 for this effect is typically 3-18mg/ml.\n\nEndotoxin: ~1EU/1ug (LAL)\n\nStorage and Stability:\nLyophilized powder may be stored at -20 degrees C. Stable for 12 months at -20 degrees C. Aliquot to avoid repeated freezing and thawing. Store at -20 degrees C. Reconstituted product is stable for 3 months at -20 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

I8435-08H

Size

25ug

Form

Supplied as a lyophilized powder in PBS, BSA. Reconstitute with sterile PBS, 0.1% BSA to 0.1mg/ml.

Purity

~95% (SDS-PAGE)

References

1. Wills-Karp, M.(2004)Immunol. Rev. 202:175. 2. Nakajima H. and K. Takatsu (2007) Int. Arch. AllergyImmunol. 142:265. 3. McKenzie, A.N. et al. (1993) Proc. Natl. Acad. Sci. 90:3735. 4. Blanco, J.C.G. et al. (2004) J. Interferon Cytokine Res. 24:21. 5. Moy, F.J. et al. (2001) J. Mol. Biol. 310:219. 6. `Eisenmesser, E.Z. et al. (2001) J. Mol. Biol. 310:231. 7.Ruetten, H. and C. Thiemermann (1997) Shock 8:409. 8.Lakkis, F.G. et al. (1997) Biochem. Biophys. Res. Commun.235:529. 9. Wynn, T.A. (2003) Annu. Rev. Immunol. 21:425.10. Andrews, A.L. et al. (2002) J. Biol. Chem. 277:46073. 11.Tabata, Y. et al. (2007) Curr. Allergy Asthma Rep. 7:338. 12. Chiaramonte, M.G. et al. (2003) J. Exp. Med. 197:687. 13. Daines, M.O. and G.K. Hershey (2002) J. Biol. Chem. 227:10387. 14. Matsumura, M. et al. (2007) Biochem. Biophys. Res. Commun. 360:464. 15. Tabata, Y. et al. (2007) J. Immunol. 177:7905. 16. Andrews, A.L. et al. (2006) J. Allergy Clin. Immunol.118:858. 17. Joshi, B.H. et al. (2006) Vitam. Horm. 74:479. 18.Andrews, A.-L. et al. (2007) J. Allergy Clin. Immunol.120:91.